Challenges and Opportunities for Chinese active pharmaceutical ingredient manufacturers Chinese API manufacturing is in a phase characterized by "rising compliance thresholds, cost and competitive pressures, and a shift toward high-end products." Short-term pains coexist with medium-term opportunities, and the key lies in differentiated transformation driven by compliance and technology.
Core Challenges (Current Situation and Causes)- Tighter Compliance and Inspections in Target...
0 Поделились
1540 Просмотры